Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2016		Dec. 31, 2015
Current Assets
Cash and cash equivalents (variable interest entity restricted - 2016: $18; 2015: $7)	$ 638		$ 967
Trade receivables - third party and affiliates (net of allowance for doubtful accounts - 2016: $6; 2015: $6; variable interest entity restricted - 2016: $4; 2015: $6)	801		706
Non-trade receivables, net	223		285
Inventories	720		682
Deferred income taxes	0		68
Marketable securities, at fair value	30		30
Other assets	60		49
Total current assets	2,472		2,787
Investments in affiliates	852		838
Property, plant and equipment (net of accumulated depreciation - 2016: $2,239; 2015: $2,039; variable interest entity restricted - 2016: $734; 2015: $772)	3,577		3,609
Deferred income taxes	159		222
Deferred Tax Assets, Net	159
Other assets (variable interest entity restricted - 2016: $9; 2015: $13)	307		300
Goodwill	796	[1]	705
Intangible assets, net (variable interest entity restricted - 2016: $26; 2015: $27)	194		125
Total assets	8,357		8,586
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates	118		513
Trade payables - third party and affiliates	625		587
Other liabilities	322		330
Deferred income taxes	0		30
Income taxes payable	12		90
Total current liabilities	1,077		1,550
Long-term debt, net of unamortized deferred financing costs	2,890		2,468
Deferred income taxes	130		136
Deferred tax liability	130
Uncertain tax positions	131		167
Benefit obligations	893		1,189
Other liabilities	215		247
Commitments and Contingencies
Stockholders' Equity
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2016 and 2015: 0 issued and outstanding)	0		0
Treasury stock, at cost (2016: 26,950,910 shares; 2015: 19,916,490 shares)	(1,531)		(1,031)
Additional paid-in capital	157		136
Retained earnings	4,320		3,621
Accumulated other comprehensive income (loss), net	(358)		(348)
Total Celanese Corporation stockholders' equity	2,588		2,378
Noncontrolling interests	433		451
Total equity	3,021		2,829
Total liabilities and equity	8,357		8,586
Series A common stock, $0.0001 par value, 400,000,000 shares authorized (2016: 167,611,357 issued and 140,660,447 outstanding; 2015: 166,698,787 issued and 146,782,297 outstanding)
Stockholders' Equity
Common stock	0		0
Series B common stock, $0.0001 par value, 100,000,000 shares authorized (2016 and 2015: 0 issued and outstanding)
Stockholders' Equity
Common stock	$ 0		$ 0

[1] There were $0 million of accumulated impairment losses as of December 31, 2016.